Evidence map›Paper›PMID 18451107›Full record

ArticleGenes & development2008

The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation.

Toshimi Yoshida, Idit Hazan, Jiangwen Zhang, Samuel Y Ng, Taku Naito, Hugo J Snippert, Elizabeth J Heller, Xiaoqing Qi, Lee N Lawton, Christine J Williams and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 183 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. It Takes a Village of Chromatin Remodelers to Regulate rDNA Expression.International journal of molecular sciences · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. How does CHD4 slide nucleosomes?Biochemical Society transactions · 2024
    Review
  12. Chromatin remodeling in tissue stem cell fate determination.Cell regeneration (London, England) · 2024
    Review
  13. AIOLOS-Associated Inborn Errors of Immunity.Journal of clinical immunology · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Toshimi YoshidaCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA. toshimi.yoshida@cbrc2.mgh.harvard.edu
Idit Hazan
Jiangwen Zhang
Samuel Y Ng
Taku Naito
Hugo J Snippert
Elizabeth J Heller
Xiaoqing Qi
Lee N Lawton
Christine J Williams
Katia Georgopoulos
Harvard University · USMassachusetts General Hospital · US

Funding

Ikaros regulation: Study on hemolymphopoiesisR01HL140622 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI KATIA GEORGOPOULOS · 2017 to 2026
$6.1M
Ikaros and Mi-2 beta interactions in early lymphoid developmentR01AI042254 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI GEORGOPOULOS, KATIA · 1998 to 2013
$5.3M
Ikaros and Mi-2 beta interactions in early lymphoid developmentR56AI042254 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI GEORGOPOULOS, KATIA · 2008 to 2008
$254k
Ikaros regulatory networks in hematopoiesisF32HL082448 · NHLBI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI LAWTON, LEE N · 2005 to 2007
$143k
NHLBI NIH HHS R01 HL140622NIAID NIH HHS R01 AI042254NIAID NIH HHS R01AI42254-12NIAID NIH HHS R56 AI042254
6 · The paper itself

Abstract

The ability of somatic stem cells to self-renew and differentiate into downstream lineages is dependent on specialized chromatin environments that keep stem cell-specific genes active and key differentiation factors repressed but poised for activation. The epigenetic factors that provide this type of regulation remain ill-defined. Here we provide the first evidence that the SNF2-like ATPase Mi-2beta of the Nucleosome Remodeling Deacetylase (NuRD) complex is required for maintenance of and multilineage differentiation in the early hematopoietic hierarchy. Shortly after conditional inactivation of Mi-2beta, there is an increase in cycling and a decrease in quiescence in an HSC (hematopoietic stem cell)-enriched bone marrow population. These cycling mutant cells readily differentiate into the erythroid lineage but not into the myeloid and lymphoid lineages. Together, these effects result in an initial expansion of mutant HSC and erythroid progenitors that are later depleted as more differentiated proerythroblasts accumulate at hematopoietic sites exhibiting features of erythroid leukemia. Examination of gene expression in the mutant HSC reveals changes in the expression of genes associated with self-renewal and lineage priming and a pivotal role of Mi-2beta in their regulation. Thus, Mi-2beta provides the hematopoietic system with immune cell capabilities as well as with an extensive regenerative capacity.

Indexed as

Adenosine TriphosphatasesAnimalsAntigens, CDAntigens, CD34ApoptosisBone Marrow CellsCell CycleCell DifferentiationCell LineageCell ProliferationCells, CulturedChromatinDNA HelicasesErythrocytesFemaleFlow CytometryAdenosine TriphosphatasesAntigens, CDAntigens, CD34CD71 antigenChromatinDNA HelicasesMi-2beta protein, mouseReceptors, Transferrin

Identifiers

PMID18451107
PMCPMC2335314
OpenAlexW2062183332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.